4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001387131-22-012291
Co-CEO & President acquired 373,857 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zanganeh Mahkam Co-CEO & President | 2022-12-06 | Other acquisition | +373,857 | 10,930,849 | D: show line 1 in the form |
Loading xslF345X03/zangeneh-form4_120622.xml…